Letter abstract


Nature Biotechnology 27, 572 - 576 (2009)
Published online: 31 May 2009 | doi:10.1038/nbt.1542

MicroRNA-mediated species-specific attenuation of influenza A virus

Jasmine T Perez1, Alissa M Pham1, Maria H Lorini2, Mark A Chua3, John Steel2 & Benjamin R tenOever1,2,3

Top

Influenza A virus leads to yearly epidemics and sporadic pandemics. Present prophylactic strategies focus on egg-grown, live, attenuated influenza vaccines (LAIVs), in which attenuation is generated by conferring temperature sensitivity onto the virus. Here we describe an alternative approach to attenuating influenza A virus based on microRNA-mediated gene silencing. By incorporating nonavian microRNA response elements (MREs) into the open-reading frame of the viral nucleoprotein, we generate reassortant LAIVs for H1N1 and H5N1 that are attenuated in mice but not in eggs. MRE-based LAIVs show a greater than two-log reduction in mortality compared with control viruses lacking MREs and elicit a diverse antibody response. This approach might be combined with existing LAIVs to increase attenuation and improve vaccine safety.

Top
  1. Microbiology Graduate School Training Program, Mount Sinai School of Medicine, New York, New York, USA.
  2. Department of Microbiology, Mount Sinai School of Medicine, New York, New York, USA.
  3. Global Health and Emerging Pathogens Institute, Mount Sinai School of Medicine, New York, New York, USA.

Correspondence to: Benjamin R tenOever1,2,3 e-mail: benjamin.tenoever@mssm.edu



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

New clues to the emergence of flu pandemics

Nature Medicine News and Views (01 Oct 1998)


Extra navigation

Open Innovation Challenges

naturejobs

ADVERTISEMENT